STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 26.68 USD 0.19% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
STAAR Surgical Co?
Write Note

STAAR Surgical Co
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

STAAR Surgical Co
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
STAAR Surgical Co
NASDAQ:STAA
Depreciation & Amortization
$5.7m
CAGR 3-Years
18%
CAGR 5-Years
10%
CAGR 10-Years
9%
Haemonetics Corp
NYSE:HAE
Depreciation & Amortization
$109.6m
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
3%
ICU Medical Inc
NASDAQ:ICUI
Depreciation & Amortization
$223.7m
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
28%
Align Technology Inc
NASDAQ:ALGN
Depreciation & Amortization
$139.9m
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
25%
Lantheus Holdings Inc
NASDAQ:LNTH
Depreciation & Amortization
$62.4m
CAGR 3-Years
17%
CAGR 5-Years
36%
CAGR 10-Years
13%
Merit Medical Systems Inc
NASDAQ:MMSI
Depreciation & Amortization
$97.7m
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
11%
No Stocks Found

STAAR Surgical Co
Glance View

Market Cap
1.3B USD
Industry
Health Care

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 692 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.

STAA Intrinsic Value
22.19 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is STAAR Surgical Co's Depreciation & Amortization?
Depreciation & Amortization
5.7m USD

Based on the financial report for Sep 27, 2024, STAAR Surgical Co's Depreciation & Amortization amounts to 5.7m USD.

What is STAAR Surgical Co's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
9%

Over the last year, the Depreciation & Amortization growth was 8%. The average annual Depreciation & Amortization growth rates for STAAR Surgical Co have been 18% over the past three years , 10% over the past five years , and 9% over the past ten years .

Back to Top